New registry aims to crack the code on tough childhood liver cancer
NCT ID NCT05556642
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is creating a registry for children and adults whose liver cancer (hepatoblastoma) has come back or not responded to treatment. Researchers will collect medical information, tumor samples, and scans from up to 500 participants to learn more about the disease. The goal is to better understand this rare cancer and pave the way for more effective treatments in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR MALIGNANT NEOPLASM, NOT OTHERWISE SPECIFIED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Targeted drug shows promise for kids with tough cancers
- New hope for young cancer patients: experimental drug targets recurrent tumors
- New hope for kids with tough cancers: Two-Drug attack on tumors
- Targeted drug ivosidenib tested in kids with rare, returning cancers
- New hope for kids with rare cancers: targeted drug selpercatinib tested in phase 2 trial
- New hope for kids with tough cancers: targeted drug attacks gene flaw